All In MedTech

FDA Clearance Tracker · P830079-S017

INSTAT COLLAGEN ABSORBABLE HEMOSTAT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 28, 2007 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 28, 2007

Approved

Time to decision

180 days

Received Jun 1, 2007. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P830079-S017
Device name
INSTAT COLLAGEN ABSORBABLE HEMOSTAT
Applicant
ETHICON, Inc.
Applicant location
Somerville, NJ
Received
Jun 1, 2007
Decided
Nov 28, 2007
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P830079

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ADDITION OF THE MANUFACTURING FACILITY LOCATED IN NORTH YORKSHIRE, UNITED KINGDOM.

Source documents

Other decisions for ETHICON, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.